| Bioactivity | Pomalidomide-PEG4-COOH is a E3 ligase ligand-linker conjugate. Pomalidomide-PEG4-COOH contains the Pomalidomide based cereblon ligand and 4-unit PEG linker used in PROTAC technology (extracted from patent WO2017184995A1)[1]. | ||||||||||||
| Name | Pomalidomide-PEG4-COOH | ||||||||||||
| CAS | 2138440-81-8 | ||||||||||||
| Formula | C24H31N3O10 | ||||||||||||
| Molar Mass | 521.52 | ||||||||||||
| Appearance | Viscous liquid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Guangrong Zheng, et al.Compounds that induce degradation of anti-apoptotic bcl-2 family proteins and the uses thereof. Patent WO2017184995A1. |
Pomalidomide-PEG4-COOH
CAS: 2138440-81-8 F: C24H31N3O10 W: 521.52
Pomalidomide-PEG4-COOH is a E3 ligase ligand-linker conjugate. Pomalidomide-PEG4-COOH contains the Pomalidomide based ce
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.